Post-Conference Perspectives: Recent Advances in the Management of Chronic GvHD - Episode 4

Role of Ruxolitinib in Steroid-Refractory Chronic GvHD

,

Dr. Chaudhary introduces data supporting the use of ruxolitinib as a first-line option in patients with steroid-refractory chronic GvHD.